Dr. Bloomgarden has a national reputation for writing and lecturing nationally and internationally on diabetes, and has authored some 300 publications in this field. He is Clinical Professor in the Department of Medicine, Division of Endocrinology, Mount Sinai School of Medicine, as well as participating in teaching rounds in the Departments of Pediatrics and Medicine.
He is a member of the Board of the American Association of Clinical Endocrinologists, and served on the Journals Managing Subcommittee of the Endocrine Society. He has worked in the American Diabetes Association as a member of the Editorial Board, and subsequently as an Associate Editor of the clinical journal, Diabetes Care, and has over the past fifteen years written the monthly “Perspectives on the News” column for this publication, a widely read and respected summary of current developments in the field, now available as an online CME activity. He is the co-Editor of the new Journal of Diabetes, an English language publication based in China. He serves on the Boards of Endocrinology today, Practical Diabetology, and Medscape Endocrinology.
Dr. Bloomgarden has acted as an advisor for a number of pharmaceutical groups. He is an honorary professor at the Biocor Hospital de Doenças Cardiovasculares, Belo Horizonte, Brazil.
He has been principal investigator in numerous studies, assessing treatment with troglitazone, glyburide, insulin, metformin, glimepiride, glipizide, fluvastatin, dichloroacetate, sildenafil, and patient education.
In his successful clinical practice, Dr. Bloomgarden is one of the best-known diabetologists in New York. He has been listed for several years in the publication, “Castle Connolly Guide: The Best Doctors New York Metro Area,” in this field.